Title
Addressing the controversy regarding the association between thimerosal-containing vaccines and autism
Other title
[La evidencia acerca de la controversia de las vacunas que contienen timerosal y su asociación con el autismo]
Date Issued
01 January 2013
Access level
metadata only access
Resource Type
review
Publisher(s)
Instituto Nacional de Salud
Abstract
Vaccination is one of the most important public health interventions in the reduction childhood morbidity and mortality. Thimerosal is an organic mercury compound used as preservante in multi-dose vials. Often in Peru, there are waves of controversy about the safety of this type of vaccines, mainly arguing that there is an association between them and autism. As a result of these controversies, there have been some voices asking for laws banning thimerosal-containing vaccines, which would have a large impact in costs and the logistic aspects of the public vaccination programs. The aim of this article is to review the literature for the main controversies about thimerosal in vaccines and its supposed association to autism. We made an historical review about these controversies given the available scientific evidence and the statements from important international organizations. We concluded that the current available evidence do not support an association between thimerosal and childhood neurodevelopmental disorders, such as autism.
Start page
268
End page
274
Volume
30
Issue
2
Language
English
OCDE Knowledge area
Psicología (incluye terapias de aprendizaje, habla, visual y otras discapacidades físicas y mentales) Farmacología, Farmacia
Scopus EID
2-s2.0-84882645139
PubMed ID
Source
Revista Peruana de Medicina Experimental y Salud Publica
ISSN of the container
17264634
Sources of information: Directorio de Producción Científica Scopus